Highlights d Human and rhesus macaque TRIM5a suppresses replication of specific flaviviruses d TRIM5a restricts tick-borne but not mosquito-borne flaviviruses d TRIM5a binds to the viral protease to promote its proteasomal degradation d TRIM5a restricts replication of sensitive flaviviruses in human DCs
In Brief
The antiviral activity of TRIM5a is thought to be limited to retroviruses as a result of highly specific interactions with capsid lattices. Here, Chiramel et al. demonstrate that TRIM5a restricts replication of specific flaviviruses by binding and degrading the viral protease.
INTRODUCTION
Flaviviruses (family Flaviviridae) include 53 recognized virus species, of which 40 are known to cause disease in humans, with over 40% of the world's population at risk of flavivirus infection annually (Brady et al., 2012) . These viruses have a high potential for emergence into human populations, as witnessed historically through global emergence of dengue virus (DENV), West Nile virus (WNV), and Zika virus (ZIKV). Additional (re)emerging viruses of considerable medical importance include yellow fever virus (YFV), Japanese encephalitis virus (JEV), and members of the tick-borne encephalitis virus (TBEV) serogroup. Flaviviruses share in common a positive-sense single-stranded RNA (ssRNA) genome encoding a single polyprotein that is cleaved by host cell signalases (Zhang et al., 2016) and the viral protease to generate three structural (capsid [C] , pre-membrane [M] , and envelope [E]) and seven nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (Lindenbach et al., 2007) . Two of the NS proteins have enzymatic activity; the NS3 protein encodes the viral RNA helicase and together with its co-factor NS2B (NS2B/3) functions as the viral protease, whereas NS5 possesses both methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRP) activities.
The repeated emergence of flaviviruses as human pathogens is in part due to the fact that they are arthropod-borne, transmitted by mosquitoes and ticks. In addition, the zoonotic reservoir species supporting virus replication in nature are highly diverse. For example, small mammals, particularly rodents, are thought critical for the maintenance of transmission cycles of TBEV and related viruses. In contrast, WNV utilizes birds, whereas DENV, ZIKV, and YFV evolved in non-human primates before at least DENV and ZIKV established urban transmission cycles maintained exclusively through human infections (Vasilakis and Weaver, 2017) . The ability of a virus to avoid or evade host antiviral responses is essential to establish replication and transmission (Versteeg and García-Sastre, 2010) . However, it is not fully understood how evolution in different reservoir hosts to avoid innate immunity has shaped replication and pathogenesis of different flaviviruses following infection of humans. Host-specific interactions with the interferon (IFN) response , dengue virus (DENV-2), Zika virus (ZIKV), or yellow fever virus (YFV) with a multiplicity of infection (MOI) of 0.001 (except YFV at MOI 0.1). Infectious virus release was determined in supernatants by plaque assay. All data are from 3 independent experiments performed in triplicate (mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s., not significant, by Mann-Whitney). Grey dotted line indicates limit of detection.
have been demonstrated for DENV and ZIKV that can only antagonize IFN-dependent signaling in the context of primate hosts (Best, 2017; Stabell et al., 2018) . However, the IFN-stimulated genes (IGSs) that might also contribute to host-specific restriction of flaviviruses are not well characterized. Tripartite motif-containing proteins (TRIMs) are strong candidates for mediating host-specific restriction of virus replication in the context of an IFN response. Approximately 100 tripartite TRIMs exist in the human genome (Han et al., 2011) , many of which are ISGs with functions as direct antiviral restriction factors or as modulators of the cellular response to infection (Rajsbaum et al., 2014) . The most characterized primate TRIM is TRIM5a, which functions as a cellular antiviral restriction factor with exquisite specificity, thought to restrict only retroviruses through complex interactions with the capsid lattice structure that accelerates uncoating of the viral nucleic acid and also blocks reverse transcription (Ganser-Pornillos et al., 2011; Stremlau et al., 2006; Wu et al., 2013) . The significant influence of TRIM5a is exemplified by the observations that its antiviral activity drives lentivirus evolution (Wu et al., 2013) and limits cross-primate species transmission . Importantly, the relative ability of TRIM5a to bind retrovirus capsid lattices directly impacts primate species susceptibility to infection. For example, TRIM5a from Old World monkeys, such as rhesus macaques (rhTRIM5a), exerts potent antiviral activity against HIV-1 to confer host resistance. In contrast, human TRIM5a (hTRIM5a) only weakly interacts with HIV-1 capsid lattices, and this reduced efficacy may promote HIV-1 transmission and disease progression (Merindol and Berthoux, 2015) . The antiviral specificity of TRIM5a has evolved rapidly in the past 30 million years of primate evolution, with particularly strong signatures of positive selection over the last 4-5 million years (Kaiser et al., 2007; Sawyer et al., 2005) . Evolutionary studies support the conclusion that TRIM5a positive selection throughout primate evolution is driven at the interaction interface between TRIM5a and retrovirus capsids and, thus, reinforce the paradigm that the antiviral activity of TRIM5a and its role in host resistance is specific to the retroviruses (McCarthy et al., 2015) .
Given the extensive evolution of multiple medically important flaviviruses with primate species, we examined the antiviral capacity of both rhTRIM5a and hTRIM5a toward the vectorborne flaviviruses. Surprisingly, both rhTRIM5a and hTRIM5a possessed potent antiviral function against specific flaviviruses within the TBEV serogroup but not toward mosquito-borne flaviviruses. The antiviral activity of TRIM5a was mediated through interactions with the viral protease NS2B/3 at sites of virus replication, and association of TRIM5a with NS2B/3 from a sensitive virus resulted in proteasomal degradation of the viral protein. Importantly, hTRIM5a contributed significantly to the antiviral effects of type I IFN against sensitive tick-borne viruses. However, TRIM5a was ineffective against important mosquito-borne flavi-viruses, including YFV, DENV, and ZIKV. Thus, this work reveals an unexpected role for primate TRIM5a as an anti-flavivirus restriction factor that may influence human susceptibility to infection.
RESULTS

TRIM5a Is a Functional Restriction Factor for Flaviviruses
The association of various mosquito-borne flaviviruses with primates prompted us to test whether ectopic expression of TRIM5a might have anti-flavivirus activity. HEK293 cells were engineered to stably express various TRIM5a proteins (Figure S1A) . The expression of rhTRIM5a restricted infection of vesicular stomatitis virus glycoprotein (VSV-G) pseudotyped HIV-1 in 293 cells, demonstrating that these cells are appropriate to observe TRIM5-mediated restriction ( Figure S1B ). Compared to empty vector control cells, expression of either hTRIM5a or rhTRIM5a restricted replication of related viruses in the TBEV serogroup, including TBEV (strain Sofjin), Kyasanur Forest disease virus (KFDV), and Langat virus (LGTV; an attenuated member of the TBEV serocomplex) but not WNV (strain NY99), DENV (strain NGC, serotype 2), ZIKV (strain 2013 French Polynesia), or YFV (strain 17D) ( Figure 1A ). TRIM5a did not affect replication of Powassan virus (POWV; strain LB) despite this virus also belonging to the TBEV serogroup. The impact of hTRIM5a or rhTRIM5a on replication of sensitive flaviviruses was significant, reducing the production of infectious virus by up to 1,000-fold during the exponential phase of virus growth. hTRIM5a was functional but less efficient, imposing a 90% reduction, but this may be attributable to the lower expression of hTRIM5a compared to rhTRIM5a ( Figure S1A ). Therefore, we also used CrFK cells stably expressing hTRIM5a-hemagglutinin (HA) as a cell model historically used to examine retrovirus restriction as they lack intrinsic TRIM5a expression . Expression of hTRIM5a suppressed replication of both TBEV ( Figure S1C ) and LGTV (an attenuated member of the TBEV serocomplex) (data not shown) but not WNV (Figure S1D) . In HEK293 cells that support more optimal flavivirus growth, restriction was observable up to a starting multiplicity of infection (MOI) of 10 ( Figure S1E ), but replication of TRIM5asensitive viruses eventually overcame restriction, which is consistent with viral saturation of antiviral restriction factors (Cowan et al., 2002;  Figure 1A) . A related hTRIM with anti-retrovirus function, TRIM22 (Tissot and Mechti, 1995) , did not impact replication of TBEV, KFDV, or LGTV, demonstrating a specific role for TRIM5a in flavivirus restriction ( Figure 1A ). Suppressed replication of KFDV was also observed at the level of protein expression, with reduced accumulation of NS3 in cells expressing hTRIM5a-HA or rhTRIM5a-HA compared to the empty vector controls ( Figure 1B) . Expression of the E protein of sensitive (B and C) NS3 protein levels in stable HEK293 cells infected with (B) KFDV or (C) POWV. The western blots are generally representative of 2 or 3 experiments, unless otherwise stated. (D) Dot plots depicting an overlay of E protein in empty vector (black) or rhTRIM5a-HA cells (red) infected with LGTV or POWV measured by flow cytometry. The percentage of cells infected as measured by E protein staining is quantified in the bar graphs (mean ± SD, data from 3 independent experiments in triplicate, *p < 0.05, one-way ANOVA with Sidak post-test). See also Figure S1 . viruses was also reduced when examined by flow cytometry ( Figure 1D ). However, no reduction in either NS3 by western blot or E expression by flow cytometry was observed following POWV infection, supporting flavivirus-species-specific restriction by TRIM5a ( Figures 1C and 1D ).
To determine if hTRIM5a is a functional restriction factor, TRIM5 mRNA was depleted by RNAi in A549 cells using lentivirus-delivered short hairpin RNA (shRNA), or TRIM5 was knocked out using CRISPR/Cas9 in Hap1 cells. Cells were left untreated or treated with IFNb for 6 h prior to infection to upregulate TRIM5 expression and induce an antiviral state. Reduced TRIM5 expression did not affect the responsiveness of cells to IFNb as measured by upregulation of canonical ISGs, RSAD2 (viperin), and CXCL10 (Figure 2A ). However, depletion of TRIM5 partially relieved the antiviral effect of IFNb on LGTV (Figure 2A) . Transfection of A549 cells with an independent small interfering (siRNA) sequence targeted toward hTRIM5a also increased replication of LGTV but not YFV ( Figure 2B ). Furthermore, deletion of TRIM5 using CRISPR/Cas9 in Hap1 cells (Figures S1F and S1G) rescued $2 log 10 LGTV replication in the presence of IFNb ( Figure 2C ). Virus replication was also increased for TBEV but not POWV, WNV, ZIKV, DENV, or YFV ( Figure 2C ). Together, these results identify TRIM5a as a restriction factor for specific species of flaviviruses and demonstrate that TRIM5a is an effector of the human type I IFN response to these viruses. A) The left panel shows qRT-PCR for TRIM5, RSAD2, or CXCL10 mRNA isolated from A549 cells following transduction with lentiviruses expressing short hairpin RNAs (shRNAs) for GFP (control) or TRIM5, and untreated or treated with IFNb (IFN) at 1000 U/ml for 6 h. The right panel shows LGTV titers in A549 cells that were left untreated or pre-treated with IFNb for 6 h and infected at an MOI of 0.001. Supernatants were collected at the indicated times and titrated by plaque assay. All data are from 3 independent experiments performed in triplicate (mean ± SD, *p < 0.05, **p < 0.01 by Mann-Whitney; ns, not significant). (B) A549 cells were transfected with siRNAs specific for TRIM5 or a non-targeting (NT) control. Cells were infected with LGTV or YFV at 48 h post-transfection (MOI, 0.001), and supernatants harvested for virus titration 48 h later. Data are from 3 independent experiments (mean ± SD, ***p < 0.001 by unpaired t test onetailed). Inset shows the relative TRIM5 mRNA expression measured by qRT-PCR in A549 cells.
(C) Replication of LGTV, TBEV, POWV, WNV, ZIKV, DENV-2, and YFV (all infected at MOI 0.1) in Hap1 cells with TRIM5 gene disruption by CRISPR/Cas9. Hap1 cells were left untreated or pretreated for 6 h with IFNb. Data are from 2-3 independent experiments performed in triplicate (mean ± SD, ***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey's multiple comparisons post-test; ns, not significant).
TRIM5a Expression Restricts Viral RNA Replication
To determine which step in the flavivirus life cycle was restricted by TRIM5a, LGTV replication was examined in rhTRIM5a-HA HEK293 cells. At 48 h post-infection (hpi), supernatants and cell lysates were subjected to three cycles of freeze-thaw lysis to compare levels of intra-and extracellular virus. In the presence of rhTRIM5a, no change in the ratio ($1:10) of intracellular: extracellular infectious virus was observed ( Figure 3A ), although intracellular accumulation of positive-sense (genomic) viral RNA was reduced by approximately 50-fold ( Figure 3B ). Viral entry was not affected, as differences in positive-sense RNA were not apparent after virus entry until at least 8-12 hpi when flavivi-rus RNA replication is initiated (Chu and Westaway, 1985; Lindenbach et al., 2007 ; Figure 3C ). Thus, TRIM5a imposes a block in virus replication at or preceding RNA replication without affecting virus entry or release. In flavivirus-infected cells, cellular localization of double-stranded RNA (dsRNA) is an obligate marker of sites of replication, and most perinuclear foci containing NS3 (the viral protease and RNA helicase) also colocalize with dsRNA, suggesting these perinuclear foci are sites of active replication (Westaway et al., 1997 ; Figure S2A ). In infected cells, small aggregates of rhTRIM5a often termed cytoplasmic bodies colocalized with NS3 and dsRNA, suggesting that TRIM5a is recruited to replication complexes (Figures 3D). RhTRIM5a aggregates also colocalized with NS5 (the viral RdRP) but only at perinuclear sites likely together with NS3 at the endoplasmic reticulum (ER) ( Figure 3E ). Recruitment of hTRIM5a to sites of NS3 expression was also observed in
LGTV-infected cells ( Figure S2B ). Areas of colocalization were observable between TRIM5a and dsRNA in the context of DENV or ZIKV, but infection did not induce strong aggregation of TRIM5a ( Figures 4A and 4B ). Next, we validated the association of either hTRIM5a or rhTRIM5a with NS3 by immunoprecipitation (IP) in LGTV-infected cells ( Figure 3F ). Despite low levels of viral protein associated with restriction, IP of NS3 from infected cells resulted in co-precipitation with either hTRIM5a or rhTRIM5a ( Figure 3F ). As expected, NS5 also co-precipitated with NS3 in infected cells, which supports the immunofluorescence assay (IFA) data and suggests that TRIM5a interactions with NS3 occur at sites of virus replication where NS3 and NS5 interact. Consistent with a lack of TRIM5a aggregation at sites of dsRNA staining ( Figures S2C and S2D ), IP of NS3 from WNV-infected cells did not result in co-precipitation of rhTRIM5a ( Figure S2E ). Thus, TRIM5a localizes to viral replication complexes and suppresses RNA replication in a flavivirus-specific manner.
TRIM5a Targets the Flavivirus Protease for Proteasomal Degradation
To examine interactions with NS3 and NS5 separately, stable rhTRIMa-HA cells were transfected with plasmids encoding LGTV NS2B/3 or NS5. NS2B was included as it forms an integral structural component of the NS3 protease active site and transmembrane domains within NS2B target NS3 to ER membranes, with NS2B/3 being an important antiviral drug target (Luo et al., 2015) . NS5 showed some co-localization with rhTRIM5a (Figure 5A) and caused low levels of TRIM5a aggregation ( Figure 5B ) but did not co-precipitate ( Figure S3A ). However, NS2B/3 expression caused rhTRIM5a to aggregate into discrete cytoplasmic bodies (Figures 5A, 5B, and S3B) and co-localize reminiscent of that observed following virus infection, and LGTV NS2B/3 strongly associated with rhTRIM5a by co-precipitation ( Figure 5G ). In addition, expression levels of NS2B/3 were reduced in cells expressing rhTRIM5a compared to the control cell line, whereas NS5 levels were not strongly affected (Figure 5C ). To further explore this observation, a constant level of LGTV NS2B/3 was expressed with increasing amounts of either rhTRIM5a or hTRIM5a by transfection of expression plasmids. In either case, expression of both unprocessed NS2B/3 and NS3 generated through autonomous cleavage was reduced in a dose-dependent fashion ( Figures 5D and 5E ), although this effect was quickly saturated. Again, the expression of LGTV NS5 was not affected by rhTRIM5a expression ( Figure 5F ). In the context of HIV-1, TRIM5a utilizes the proteasome (MG132 sensitive) for capsid disruption but not for restriction (Kutluay et al., 2013) and may also use lysosomes following autophagy (BafA1-sensitive) to degrade the capsid (Mandell et al., 2014a; Ribeiro et al., 2016) . Treatment of NS2B/3-expressing cells with BafA1 to inhibit lysosomal degradation increased the expression of NS2B/3 when expressed alone but did not rescue the relative loss of NS2B/3 in the presence of rhTRIM5 ( Figures  5H and 5I ). This was despite the BafA1-sensitive rescue of p62/SQSTM1, which is a reported co-factor to TRIM5-mediated retrovirus restriction (O'Connor et al., 2010;  Figure 5H ). Selective autophagy of the HIV-1 capsid by TRIM5a is also mediated by Beclin, ATG5, p62, GABARAP, and LC3 (Mandell et al., 2014a) , but siRNA-mediated knock down of these genes did not significantly relieve LGTV restriction ( Figures S4A-S4C ). Finally, the C-type lectin langerin, but not DC-SIGN, was previously shown to be sufficient for autophagic degradation of the HIV-1 capsid by hTRIM5a (Ribeiro et al., 2016) . However, although DC-SIGN augmented LGTV replication as expected in its role as a flavivirus attachment factor (Davis et al., 2006) , langerin expression had no effect and did not further increase the restriction of LGTV in TRIM5a-expressing cells ( Figure S4D ), strongly suggesting that selective autophagy following virus entry or establishment of viral replication complexes is not the main mechanism of restriction. In contrast, treatment with epoxomicin ( Figures 5H and 5I ) recovered the majority of NS3 in the presence of rhTRIM5a, implicating proteasomal degradation of NS2B/3. This was supported by reciprocal IP of NS2B/3 ectopically co-expressed with rhTRIM5 in the presence of epoxomicin demonstrating (1) increased interactions between TRIM5a and both the uncleaved NS2B/3 precursor and the mature, autocleaved NS3 protein, and (2) increased ubiquitination of NS2B/3 co-precipitating with TRIM5a ( Figure 5G ). TRIM5a did not appear to affect protease activity, as autocleavage to produce NS3 measured by the ratio of NS2B/3:NS3 did not change in the presence of TRIM5a (Figure S4E ). Furthermore, overexpression of K48R-HA ubiquitin (Ub) that cannot make K48-linked Ub chains, but not K63R-HA Ub, rescued expression of both NS2B/3 and rhTRIM5a ( Figure 5J ), further suggesting that NS2B/3 degradation involves K48-linked ubiquitination, which generally involves the proteasome.
To determine the domain of NS2B/3 recognized by TRIM5a, degradation assays were performed on various truncated NS2B/ 3 constructs ( Figure 5K ). NS3 expressed without NS2B (Figure S4F) or the NS3 helicase domain alone ( Figure S4G ) was not sufficient for TRIM5a-mediated degradation. A construct containing the entire NS2B protein fused to the NS3 protease domain (NS2B-NS3pro) was also not degraded, suggesting that NS2B alone is not sufficient as a target ( Figure S4H ). However, expression of NS3pro containing the 40 amino acids of NS2B required for NS3 protease activity in frame with a flexible glycine linker, the NS3 protease domain and the linker sequence between the NS3 protease and helicase domains, enabled degradation ( Figure 5L) . Thus, the target for TRIM5a degradation requires NS2B in addition to NS3 sequences (NS3pro). Recognition of NS2B/3 is, therefore, likely dependent on protease conformation but is independent of protease activity, as the S138A active site mutant of NS2B/3 was also degraded ( Figure S4I ). of cytoplasmic bodies (Fletcher et al., 2018) . The specificity of TRIM proteins is mainly determined by their C-terminal B30.2/ SPRY domain that is responsible for binding to specific substrates, including retroviral capsids (Sawyer et al., 2005) . The C15/18A RING mutant of rhTRIM5a did not degrade NS2B/3 ( Figure 6A ) and instead stabilized it consistent with retention of binding ( Figure 6B ). Restriction of infectious virus production was also dependent on rhTRIM5a RING function, particularly at early times post-infection ( Figure 6D ). Compared to co-expression of LGTV NS2B/3 with WT-rhTRIM5a-HA, the C15/18A RING mutant retained strong colocalization by IFA but lost the ability to form discrete cytoplasmic bodies (Figures 6E and 6F) . In contrast, deletion of the B30.2/SPRY domain eliminated degradation of NS2B/3 ( Figure 6A ) associated with failure to bind NS3 in infected cells ( Figure 6C ), reduced colocalization with ectopically expressed NS2B/3 ( Figure 6F ), and the loss of antiviral activity ( Figure 6D ). Importantly, these data directly link TRIM5a binding and degradation of NS2B/3 to its antiviral restriction capacity in the context of flaviviruses.
In the context of retroviruses, capsid binding by cyclophilin A (CypA) is required for virus replication (Gamble et al., 1996; Luban et al., 1993) , and substitution of the B30.2/SPRY domain of hTRIM5a with CypA facilitates hTRIM5a binding to HIV-1 and virus restriction (Luban, 2007 (Luban, , 2012 . The tick-borne flaviviruses, including LGTV, are sensitive to Cyp inhibition ( Figure S5A ; Chiramel et al., 2016) , and CypA specifically is required for efficient virus replication ( Figure S5B ). However, although substitution of owl monkey CypA (Sayah et al., 2004) or human CypA (Gamble et al., 1996) for the hTRIM5a B30.2/SPRY domain suppressed replication of VSV-G pseudotyped HIV-1 (Figures S1A and S1B), these fusion proteins had no effect on replication of LGTV ( Figures S5C and S5D) . Thus, although CypA is required for flavivirus replication and binds to NS proteins NS5 (Qing et al., 2009 ) and NS4B (Vidotto et al., 2017) within viral replication complexes, TRIM5-CypA fusion proteins are not sufficient to restrict tick-borne flavivirus replication, con-firming the importance of the B30.2/SPRY domain of TRIM5a in flavivirus restriction.
Endogenous hTRIM5a Is an Antiviral Restriction Factor for Flaviviruses
The role of hTRIM5a in suppression of HIV-1 has been controversial, in part because early studies suggested no restriction of laboratory strains of HIV-1. However, recent studies suggest that cytotoxic T lymphocyte (CTL)-selected HIV-1 isolates from so-called ''elite controllers'' are susceptible to restriction by hTRIM5a (Merindol et al., 2018) , and genetic studies suggest that human polymorphisms in TRIM5 impact disease progression (Merindol and Berthoux, 2015) . To further examine whether TRIM5a in human cells restricts flavivirus replication, we first immunoprecipitated LGTV NS2B/3 following ectopic expression in unmodified HEK293 cells, which revealed an interaction with endogenous TRIM5a ( Figure 7A ). Treatment of these cells with epoxomicin increased the levels of co-precipitating TRIM5 and NS2B/3 as well as the presence of endogenous K48-linked Ub smears in the complex ( Figure 7B ), whereas depletion of TRIM5a by CRISPR/Cas9-mediated gene editing both increased levels of NS3 and decreased endogenous K48-linked Ub smears in the precipitates ( Figure 7C ). Endogenous interactions between NS3 and TRIM5a were also confirmed in the HAP1 cells knocked out for TRIM5a by CRISPR/Cas9 and infected with LGTV (Figure 7D) . Finally, infection of primary human-monocyte-derived dendritic cells (DCs) resulted in upregulation of TRIM5 expression ( Figure 7E ). Silencing of TRIM5 expression in human DCs by lentivirus-delivered shRNA expression increased the release of infectious KFDV by approximately 170-fold at 48 hpi compared to cells expressing shRNA specific for luciferase as a control (Figures 7F and 7G) . No effect of TRIM5a silencing was observed following infection with ZIKV ( Figure 7H ). Together, these data demonstrate that hTRIM5a is a bona fide restriction factor for specific flaviviruses that functions through interactions with the viral replication complex and proteasomal degradation of NS3. LGTV NS2B/3-V5 and rhTRIM5a-FLAG were co-expressed with ubiquitin (Ub)-HA wild type (WT) or K48R or K63R mutants in HEK293 cells. Target proteins were immunoprecipitated using anti-V5 or anti-FLAG antibodies and blots probed with anti-HA to examine Ub conjugation. (K) Domain structure of flavivirus NS2B/3 (PDB: 2vbc) and schematic representation of truncation mutants. (L) Western blot analysis of HEK293 cells transfected with increasing amounts of rhTRIM5a-HA and constant amounts of LGTV NS3pro. Lysates were probed specifically for HA, V5 and b-actin. See also Figure S3 and S4. (legend continued on next page)
DISCUSSION
TRIM5a functions as an intrinsic cellular restriction factor that recognizes retrovirus capsids with high specificity and with definitive consequences for primate susceptibility to HIV-1 infection (Ganser-Pornillos et al., 2011; Hatziioannou et al., 2006; Merindol and Berthoux, 2015; Stremlau, 2007; Stremlau et al., 2004; Stremlau et al., 2006; Wu et al., 2013) . Here, we show that both hTRIM5a and rhTRIM5a restrict replication of specific flaviviruses within the TBEV serocomplex and that endogenous TRIM5a is required for the antiviral effects of type I IFN against sensitive flaviviruses in human cells. The viruses sensitive to TRIM5a included TBEV, KFDV, and LGTV but interestingly not POWV. However, mosquito-borne YFV, DENV, ZIKV, and WNV were not sensitive to rhTRIM5a-mediated restriction. We further identified the viral protease NS2B/3 as a major target recognized by the SPRY/B30.2 domain of TRIM5a. NS2B/3 is responsible for a number of cleavage events of the viral polyprotein, and NS3 additionally encodes the RNA helicase essential to viral RNA replication (Lindenbach et al., 2007) . NS3 also contributes to virus particle assembly (Gebhard et al., 2016) , and NS2B/3 has been shown for some flaviviruses to cleave host proteins involved in antiviral sensing and production of type I IFN (Aguirre et al., 2012; Yu et al., 2012) . Thus, the essential role of NS2B/3 in virus replication explains the generalized effect of TRIM5a in reducing viral RNA replication, protein expression, and production of infectious progeny. Taken together, this work significantly extends the paradigm of TRIM5a as an antiviral restriction factor and suggests that, in contrast to the current view, TRIM5a exhibits a remarkable plasticity in recognition of unrelated viruses. The precise molecular determinant recognized by TRIM5a was not finely mapped but required both the cytoplasmic domain of NS2B that contributes to NS3 protease structure and function, as well as the linker region between protease and helicase domains. The linker domain is functionally important in directing the conformation of the viral helicase relative to the ER membrane and to the protease domain in order to regulate polyprotein processing and genome replication (Luo et al., 2010) . Thus, binding of the linker domain by TRIM5a may result in steric hindrance of NS3 function in addition to protein degradation. Indeed, mutation of the TRIM5a RING domain prevented NS3 degradation but was still able to impact a weak level of restriction of LGTV replication. The requirement for NS2B sequences that contribute to the protease structure suggests that the binding requirements of TRIM5a are dependent on NS2B/3 conformation. Interestingly, targeting the E3 ligase activity of TRIM5 to sites of tick-borne flavivirus replication through fusion with CypA is not sufficient to restrict infection, despite a clear requirement for CypA in flavivirus replication (Chiramel et al., 2016; Qing et al., 2009; Vidotto et al., 2017) , perhaps because CypA binds to different NS proteins (NS5, NS4A) (Qing et al., 2009; Vidotto et al., 2017) than does TRIM5a. These results suggest highly coordinated activities of the SPRY/ B30.2 and RING domains in NS2B/3 binding and effector functions, respectively. Therefore, thorough mapping and structural studies are required to precisely delineate TRIM5a interactions with NS2B/3 and how this compares with known structural determinants governing the TRIM5a interaction with retrovirus capsid lattices.
The rapid evolution of the TRIM5 gene throughout primate evolution is associated with selection pressure from lentivirus capsid sequences (McCarthy et al., 2015) . It is, therefore, unclear how evolutionary selection of TRIM5a for retrovirus restriction has left the protein with enough flexibility to maintain antiviral activity against flaviviruses. It may be possible that ancient flavivirus-like viruses have influenced the evolution of hTRIM5a. However, the time frame of flavivirus evolution is in the order of thousands of years in contrast to millions of years for retroviruses and the TRIM5 gene (Kaiser et al., 2007) . Flaviviridae includes the more ancient genera of Hepaciviruses, although evidence for a zoonotic origin of hepatitis C virus (HCV) in non-human primates is not strong despite the extremely narrow host range of HCV limited to humans and chimpanzees (Simmonds, 2013) . Therefore, it seems unlikely that flaviviruses influenced the positive selection of the TRIM5 gene within the human lineage. However, our work raises the possibility that human polymorphisms within the TRIM5 locus could influence resistance to infection with medically important flaviviruses. Thus, understanding the genetic trade-offs in both TRIM5a and NS2B/3 that enable restriction of flaviviruses versus retroviruses represent an important model to illustrate how host resistance is shaped by multiple pathogens and might provide new insight to human susceptibility to emerging flaviviruses.
Among the tick-borne flaviviruses tested, POWV was insensitive to TRIM5a-mediated restriction. This raises the question of how flaviviruses escape restriction and whether this has implications for host tropism and evolution of these viruses. Despite the close genetic relationship between POWV and other tick-borne viruses sharing $80%-87% amino acid identity across NS3, it is possible that encodes NS2B/3 sequences that are not bound by TRIM5a, as was observed for WNV. Alternatively, virus-specific interactions between the flavivirus replication complex and CypA might protect against TRIM5 binding, as was recently reported for HIV-1 (Kim et al, 2019) . Finally, it is possible that some flaviviruses may encode an antagonist of TRIM5a activity. Detailed mapping studies to identify viral determinants of TRIM5a binding and degradation will shed light on these potential evasion strategies and will further enable studies examining the role of TRIM5a in primate immunity to infection.
Although primates have a single TRIM5 gene, rodents have an expanded clade of TRIM5 genes with at least seven TRIM5 paralogs in mice that cluster into two groups designated TRIM30 (D) LGTV replication kinetics in HEK293 cells stably expressing rhTRIM5a-HA, RING mutant rhTRIM5(C15/C18A)-HA, rhTRIM5-delta SPRY, or the empty vector control following infection at MOI of 0.001. All data are from 3 independent experiments in triplicates (mean ± SD, *p < 0.05 Mann-Whitney test). (E and F) HEK293 cells were co-transfected with LGTV NS2B/3-V5 (shown expressed alone in E), WT rhTRIM5a-HA, RING mutant rhTRIM5(C15/C18A)-HA, or rhTRIM5-delta SPRY-HA (F). Slides were fixed and processed for indirect immunofluorescence staining with antibodies specific for HA (green) and V5 (red), and nuclei were counterstained with DAPI (blue). Images were analyzed using confocal microscopy with fluorescence intensity profiles measured across the white line of insets to demonstrate colocalization using Zen Imaging software. Scale bar, 10 mm. See also Figure S5 . and TRIM12 (Tareen et al., 2009) . TRIM12 genes possess antiretroviral activity, although a function in retrovirus restriction has not been observed for TRIM30 genes (TRIM30-a, -b, -c, and -d) (Lascano et al., 2015; Tareen et al., 2009) . We previously demonstrated that TRIM30-d (also known as TRIM30-3 or TRIM79) restricts replication of a subset of flaviviruses within the TBEV serogroup . TRIM30-d interacted with and degraded the viral NS5 protein that is essential for virus replication owing to its MTase and RdRP functions and its role as an antagonist of IFN-I-dependent signaling (Best, 2017; Best et al., 2005; Laurent-Rolle et al., 2010) . TRIM30-d directed the destruction of NS5 complexed with NS3 by lysosomes, consistent with the ability of lysosomes to accommodate the degradation of large protein complexes (potentially through autophagy) (Mandell et al., 2014b; Sparrer et al., 2017) , although TRIM30d did not degrade NS2B/3 expressed in the absence of NS5 . Like TRIM5a, restriction of virus replication by TRIM30-d appeared specific to tick-borne flaviviruses, including LGTV, POWV, and TBEV, because TRIM30-d did not inhibit the replication of WNV . Rodents are required for the maintenance of tick-borne flaviviruses in nature by enabling tick co-feeding and transfer of virus from infected to uninfected ticks in the absence of detectable viremia (Kazimírová et al., 2017) . However, despite the parallels in antiviral activity between TRIM30-d and TRIM5a, it is unlikely that flavivirus sensitivity to TRIM30-d directly influenced sensitivity to primate TRIM5a, as the targeted viral proteins and mechanisms of antiviral activity are unrelated. Instead, the evolutionary history of tick-borne flaviviruses in rodents suggests that the TRIM30d/NS5 interaction has arisen independently to TRIM5/NS2B-3 interactions.
In summary, the finding that primate TRIM5a can recognize and degrade NS2B/3 from specific flaviviruses combined with a strong antiviral role in the type I IFN response suggests that TRIM5 has a high potential to function as an important human barrier to infection with emerging flaviviruses. We speculate that resistance to TRIM5a-mediated restriction may be an important factor in enabling the use of primates as reservoirs for viruses such as YFV, DENV, and ZIKV. Regardless, these findings reveal an alternative model to retroviruses to explore the structure and function of TRIM5a in human resistance to virus infection.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Oligonucleotides Probes for qRT-PCR used in this study Applied Biosystems Table S1 siRNAs used in this study (SMARTpool) Horizon (Dharmacon) Table S2 Primers for cloning TRIM5 constructs Integrated DNA Technologies Table S3 shRNA sequence of lentiviral constructs (Control -Luciferase) three time with PBS(1X) and once with ddH 2 0, and mounted onto glass coverslips using Prolong Gold + DAP1 mounting media (Molecular Probes). Processed slides were imaged using a Zeiss LSM710 confocal microscope and vector profiles analyzed using Zen software (Carl Zeiss).
Flow cytometry
Cells were harvested at 48 hpi and processed for flow cytometry analysis. Cells were stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (ThermoFisher) and fixed with 4% paraformaldehyde for 20 min at RT. Cells were permeabilized with saponin-containing buffer and probed with anti-E 11H12 antibody. Data were generated using an LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo (Tree Star).
RNA Isolation and quantitative RT-PCR RNA was isolated from cells using RNeasy kit (QIAGEN) and genomic DNA was removed with RNase-free DNase (QIAGEN). Reverse transcription of RNA was performed using Superscript Vilo cDNA Synthesis Kit (Invitrogen) according to manufacturer's protocol. TaqMan probes (Table S1 ) specific for TRIM5, hypoxanthine-guanine phosphoribosyltransferase (HPRT), interferon beta (IFNb), interlukin À6 (IL6), tumor necrosis factor alpha (TNFa) and C-X-C motif chemokine 10 (CXCL10) were obtained from Applied Biosystems. Reactions for Real-time RT-PCR were set up in triplicate, cycled and data was collected on the Applied Biosystems GeneAmp 9500 Sequence detection system. Quantification of relative gene expression was relative to untreated controls with comparative C T method.
RNA interference HEK293 and A549 cells were transfected with 15 pmol of siRNA using Lipofectamine RNAiMAX (Life Technologies), refer Table S2 . siRNAs (Dharmacon; SMART pool) were specific against TRIM5 (L-007100), LC3B (L-012846), GABARAP (L-012368), Beclin-1 (L-010552), ATG5 (L-004374) and p62 (L-010230).
Quantification and statistical analysis
All data were evaluated for significance using one-tailed unpaired Student's t test, or Mann-Whitney U test or one-way/two-way ANOVA GraphPad Prism 7 software. The number of experimental and technical replicated for statistical analysis is indicated in each figure legend. Data involving virus titrations were generated with values over 2-3 experimental replicates performed in triplicates and analyzed for significance using Mann-Whitney U test or one-way ANOVA post-test as indicated, in figure legends. Western blots and experiments involving immunofluorescence were generally performed a minimum of two times, unless quantification was performed in which case the number of experiments is listed in the figure legends. Quantitative image analysis were measured along vectors drawn in at least 3 fields of cells and validated for significance using two-way ANOVA with Sidak's or Dunnett's post-test, as indicated in figure legends.
